medigraphic.com
ISSN 2007-4360 (Print)
Asociación Mexicana de Periodontología, Colegio de Periodoncistas A.C

2021, Number 1-3

<< Back Next >>

Rev Mex Periodontol 2021; 12 (1-3)

Periodontal disease and COVID-19: risk factors and shared mechanisms

Baltazar-Díaz TA, Zamora-Pérez AL

Language: Spanish
References: 67
Page: 12-17
PDF size: 265.51 Kb.


ABSTRACT

Periodontal disease comprises different stages, all of them being the consequence of inflammatory conditions of the periodontium, induced by a pathological imbalance of the oral microbiota. The current COVID-19 pandemic, caused by SARS-CoV-2 has strong implications in various areas of medicine, however, the entry of the virus through the upper respiratory tract and the relevance of the oral cavity for the control of infections emphasize the importance of reviewing the different findings around COVID-19 and oral health. This short review multiple risk factors common to periodontal disease and the development of COVID-19, in which different hypotheses and mechanisms that could establish associations between both pathologies are inspected. The identification of risk groups during the pandemic is very important to establish public health recommendations, that is why then knowledge about highly prevalent pathologies such as periodontal disease is of special significance.


REFERENCES

  1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA [Internet]. 2020 Mar 17;323(11):1061. Available from: https://jamanetwork.com/journals/jama/fullarticle/2761044

  2. Johns Hopkins University. Coronavirus Resource Center [Internet]. 2020 [cited 2020 Dec 12]. Available from: https://coronavirus.jhu.edu/map.html

  3. Dirección General de Epidemiología. Covid-19 México [Internet]. 2020 [cited 2020 Dec 12]. Disponible en: https://datos.covid-19.conacyt.mx/

  4. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Prim [Internet]. 2017; 3: 1-14. Available from: http://dx.doi.org/10.1038/nrdp.2017.38

  5. Ortiz-García Y, García-Iglesias T, Hernández-Hernández A, Morales V, Cervantes-Cabrera J, Zamora-Pérez A. Factor inhibidor de la migración de macrófagos en la enfermedad periodontal. Rev Mex Periodontol. 2018; 9 (1-2): 14-19.

  6. Borges-Yáñez SA, Irigoyen-Camacho ME, Maupomé G. Risk factors and prevalence of periodontitis in community-dwelling elders in Mexico. J Clin Periodontol. 2006; 33 (3): 184-194.

  7. Rojo BNR, Flores EA, Arcos CM. Prevalencia, severidad y extensión de periodontitis crónica. Rev Odont Mex. 2011; 15 (1): 31-39.

  8. Orozco JR, Peralta LH, Palma MG, Pérez RE, Arróniz PS, Llamosas HE. Prevalencia de gingivitis en adolescentes en el municipio de Tlalnepantla. Rev ADM. 2002; 59 (1): 16-21.

  9. Irigoyen ME, Velázquez C, Zepeda MA, Mejía A. Caries dental y enfermedad periodontal en un grupo de personas de 60 o más años de edad de la Ciudad de México. Rev ADM. 1999; 56 (2): 64-69.

  10. Medina-Solís CE, Ávila-Burgos L, Hidalgo D. Políticas de salud bucal en México: Disminuir las principales enfermedades. Una descripción. Rev Biomed. 2006; 17 (4): 269-286.

  11. Dirección General de Epidemiología. Resultados del Sistema de Vigilancia Epidemiológica de Patologías Bucales SIVEPAB 2019. 2019.

  12. Bao L, Zhang C, Dong J, Zhao L, Li Y, Sun J. Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection. Front Microbiol. 2020; 11: 1-13.

  13. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271-280.e8.

  14. Hoffmann M, Kleine-Weber H, Pohlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020; 78 (4): 779-784.e5.

  15. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A et al. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J Clin Endocrinol Metab. 2020; 105 (8): 2752-2761.

  16. Hernández-Galdamez DR, González-Block MÁ, Romo-Dueñas DK, Lima-Morales R, Hernández-Vicente IA, Lumbreras-Guzmán M et al. Increased risk of hospitalization and death in patients with covid-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res. 2020; 51 (7): 683-639.

  17. Mancini L, Quinzi V, Mummolo S, Marzo G, Marchetti E. Angiotensin-converting enzyme 2 as a possible correlation between COVID-19 and periodontal disease. Appl Sci. 2020; 10 (18): 6224.

  18. Kara C, Celen K, Dede FO, Gokmenoglu C, Kara NB. Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3. Exp Biol Med. 2020; 245 (16): 1425-1427.

  19. Madapusi Balaji T, Varadarajan S, Rao USV, Raj AT, Patil S, Arakeri G et al. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression. Med Hypotheses [Internet]. 2020; 144: 109936. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0306987720311476

  20. Polak D, Sanui T, Nishimura F, Shapira L. Diabetes as a risk factor for periodontal disease-plausible mechanisms. Periodontol 2000. 2020; 83 (1): 46-58.

  21. Martinez-Herrera M, Silvestre-Rangil J, Silvestre FJ. Association between obesity and periodontal disease. A systematic review of epidemiological studies and controlled clinical trials. Med Oral Patol Oral Cir Bucal. 2017; 22 (6): e708-715.

  22. Chaffee BW, Weston SJ. Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol. 2010; 81 (12): 1708-1724.

  23. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol. 2005; 76 (11-s): 2075-2084. Available from: http://doi.wiley.com/10.1902/jop.2005.76.11-S.2075

  24. Wahid A, Chaudhry S, Ehsan A, Butt S, Khan AA. Bidirectional relationship between chronic kidney disease & periodontal disease. Pakistan J Med Sci. 2012; 29 (1): 211-215.

  25. Ioannidou E, Hall Y, Swede H, Himmelfarb J. Periodontitis associated with chronic kidney disease among Mexican Americans. J Public Health Dent [Internet]. 2013; 73 (2): 112-119. Available from: http://doi.wiley.com/10.1111/j.1752-7325.2012.00350.x

  26. De la Rosa E, Irigoyen M, Aranda S, Cruz S, Mondragón A. Enfermedad periodontal en pacientes diabéticos con y sin insuficiencia renal crónica. Rev Med Inst Mex Seguro Soc [Internet]. 2007; 45 (5): 437-446. Disponible en: https://pdfs.semanticscholar.org/3b6e/868094a63e4d23a637b1030769b85a39fa2a.pdf

  27. Hobbins S, Chapple I, Sapey E, Stockley R. Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors? Int J Chron Obstruct Pulmon Dis [Internet]. 2017; 12: 1339-1349. Available from: https://www.dovepress.com/is-periodontitis-a-comorbidity-of-copd-or-can-associations-be-explaine-peer-reviewed-article-COPD

  28. Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann Periodontol. 2003; 8 (1): 54-69. Available from: http://doi.wiley.com/10.1902/annals.2003.8.1.54

  29. Hajishengallis E, Hajishengallis G. Neutrophil Homeostasis and Periodontal Health in Children and Adults. J Dent Res [Internet]. 2014; 93 (3): 231-237. Available from: http://journals.sagepub.com/doi/10.1177/0022034513507956

  30. Scott DA, Krauss JL. Neutrophils in periodontal inflammation. In: Periodontal disease [Internet]. 2011. 56-83. Available from: https://www.karger.com/Article/FullText/329672

  31. Usher AK, Stockley RA. The link between chronic periodontitis and COPD: a common role for the neutrophil? BMC Med [Internet]. 2013; 11 (1): 241. Available from: http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-241

  32. Roberts HM, Ling MR, Insall R, Kalna G, Spengler J, Grant MM et al. Impaired neutrophil directional chemotactic accuracy in chronic periodontitis patients. J Clin Periodontol [Internet]. 2015; 42 (1): 1-11. Available from: http://doi.wiley.com/10.1111/jcpe.12326

  33. World Health Organization. Classification of diabetes mellitus. Geneva; 2019.

  34. Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V et al. Prevalencia de diabetes y descontrol glucémico en Mexico: resultados de la Ensanut 2016. Salud Publica Mex. 2020; 62 (1): 50-59.

  35. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012; 55 (1): 21-31.

  36. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020; 23 (5): 1416-1424.

  37. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020; 36 (7): 1-9.

  38. Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. Nutr Metab Cardiovasc Dis [Internet]. 2020; 30 (8): 1236-1248. Available from: https://doi.org/10.1016/j.numecd.2020.05.014

  39. Li Y, Xu Q, Ma L, Wu D, Gao J, Chen G et al. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2. J Cell Mol Med. 2020; 24 (16): 9478-9482.

  40. Patel VB, Parajuli N, Oudit GY. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clin Sci. 2014; 126 (7): 471-482.

  41. Fernandez C, Rysa J, Almgren P, Nilsson J, Engström G, Orho-Melander M et al. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Intern Med. 2018; 284 (4): 377-387.

  42. Oliveira SHP, Brito VGB, Frasnelli SCT, Ribeiro B da S, Ferreira MN, Queiroz DP et al. Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease. Front Pharmacol. 2019; 10: 1-16.

  43. World Health Organization. Diet, nutrition and the prevention of chronic diseases. World Health Organization technical report series. Vol. 916, Switzerland; 2003.

  44. Huttunen R, Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes. 2013; 37 (3): 333-340.

  45. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020; 28 (7): 1195-1199.

  46. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes [Internet]. 2012; 36 (8): 1072-1077. Available from: http://dx.doi.org/10.1038/ijo.2011.208

  47. Jia X, Yin C, Lu S, Chen Y, Liu Q, Bai J et al. Two things about COVID-19 might need attention. Preprints. 2020; 2:

  48. Araújo MVF, Hong BY, Fava PL, Khan S, Burleson JA, Fares G et al. End stage renal disease as a modifier of the periodontal microbiome. BMC Nephrol. 2015; 16 (1): 1-7.

  49. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19. Aging (Albany NY). 2020; 12 (7): 6049-6057.

  50. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol [Internet]. 2020; 52 (6): 1193-1194. Available from: https://doi.org/10.1007/s11255-020-02451-9

  51. From the Global Strategy for the Diagnosis, Management and Prevention of COPD GI for COLD (Gold) 2017. AFHO. Guías para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Neumol Cir Torax. 2012; 71 (1): 1-89.

  52. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of national health and nutrition examination survey III. J Periodontol [Internet]. 2001; 72 (1): 50-56. Available from: http://doi.wiley.com/10.1902/jop.2001.72.1.50

  53. Scannapieco FA. Individuals with chronic obstructive pulmonary disease (COPD) may be more likely to have more severe periodontal disease than individuals without COPD. J Evid Based Dent Pract [Internet]. 2014; 14 (2): 79-81. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1532338214000761

  54. Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. too little, too late or too much, too soon? Am J Respir Cell Mol Biol [Internet]. 2013; 48 (5): 531-539. Available from: http://www.atsjournals.org/doi/abs/10.1165/rcmb.2012-0492TR

  55. Burnett D, Hill S, Chamba A, Stockley R. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet [Internet]. 1987; 330 (8567): 1043-1046. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673687914760

  56. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N et al. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol [Internet]. 2020; 92 (10): 1915-1921. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jmv.25889

  57. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. Bhatt GC, editor. PLoS One [Internet]. 2020; 15 (5): e0233147. Available from: https://dx.plos.org/10.1371/journal.pone.0233147

  58. Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J [Internet]. 2020; 55 (5): 2000688. Available from: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.00688-2020

  59. Maremanda KP, Sundar IK, Li D, Rahman I. Age-dependent assessment of genes involved in cellular senescence, telomere, and mitochondrial pathways in human lung tissue of smokers, COPD, and IPF: associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis. Front Pharmacol. 2020; 11: 1-16.

  60. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014; 64 (1): 57-80.

  61. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: The polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012; 27 (6): 409-419.

  62. Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions [Internet]. Vol. 16, Nature Reviews Microbiology. Springer US; 2018, 745-759. Available from: http://dx.doi.org/10.1038/s41579-018-0089-x

  63. Ai D, Huang R, Wen J, Li C, Zhu J, Xia LC. Integrated metagenomic data analysis demonstrates that a loss of diversity in oral microbiota is associated with periodontitis. BMC Genomics [Internet]. 2017; 18 (Suppl 1): 1-15. Available from: http://dx.doi.org/10.1186/s12864-016-3254-5

  64. Duran-Pinedo AE, Chen T, Teles R, Starr JR, Wang X, Krishnan K et al. Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J. 2014; 8 (8): 1659-1672.

  65. Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis [Internet]. 2020; 71 (15): 713-720. Available from: https://academic.oup.com/cid/article/71/15/713/5780800

  66. Moore SC, Penrice-Randal R, Alruwaili M, Dong X, Pullan ST, Carter DP et al. Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19. medRxiv [Internet]. 2020; 2020.03.05.20032011. Available from: http://medrxiv.org/content/early/2020/03/08/2020.03.05.20032011.abstract

  67. Khan AA, Khan Z. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak. Bioinformatics. 2020; 36 (13): 4065-4069.




2020     |     www.medigraphic.com